← Open Payments lookup

OVAYOZA ADELEYE: Open Payments

NPI 1538150263 · NATCHITOCHES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,099 in 60 payments from 11 companies in 2025. Trend: 2023 $908 · 2024 $629 · 2025 $1,099

Food & beverage: $1,032Education: $66
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$247
ABBVIE INC.15$228
Teva Pharmaceuticals USA, Inc.8$208
Otsuka America Pharmaceutical, Inc.6$121
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$61
Vanda Pharmaceuticals Inc.3$54
Collegium Pharmaceutical, Inc.3$54
Alkermes, Inc.3$45
Axsome Therapeutics, Inc.3$43
Lundbeck LLC1$22

Products named: INGREZZA, VRAYLAR, AUSTEDO XR, ABILIFY ASIMTUFII, CAPLYTA, FANAPT, Jornay PM, ARISTADA.

Industry payments across LA — which companies pay providers there.